Delivery Order SPE2DB22D2006-SPE2DB25FV8QY

Award Date 2/25/25
Potential Completion Date 2/26/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Oxycontin ER 80 mg tablets. The contract is a firm fixed-price contract with a ceiling value of $4,760.59 and an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of OxyContin ER 20 mg tablets, a prescription opioid medication. The contract has a ceiling value of $1,451.82 and is a firm fixed-price delivery order with a completion date of July 26, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the pharmaceutical distributor AmerisourceBergen Drug Corporation for the supply of OxyContin ER 30 mg tablets. The contract award is valued at $2,086.80 and has an ultimate completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which is valued at up to $999,999,999 through December...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation (AmerisourceBergen) for the supply of OxyContin ER 10 mg tablets. The contract has a ceiling value of $1,227.46 and an ultimate completion date of July 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $6,319.02 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,735 units of OxyContin ER 40 mg tablets, with a period of performance through September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 and running through...
This is a $1,022.64 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of OxyContin ER 40 mg tablets in 100-count bottles. The award represents a task order under Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OxyContin ER 80 mg tablets. The contract has a ceiling value of $2,536.35 and is a firm fixed-price delivery order that runs through November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100-count bottles of the prescription medication OxyContin ER 80 mg tablets. The order, valued at $16,556.60, has a firm fixed price and an ultimate completion date of September 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,359.18, is a delivery order for the supply of Oxycontin ER 20 mg tablets. The contract has an ultimate completion date of January 8, 2025 and a firm fixed price pricing type. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.96 delivery order is for the supply of OxyContin ER 20 mg tablets. It is placed under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8QY
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OxyContin ER 20 mg tablets. The contract has a firm fixed price of $3,793.29 and a completion date of February 26, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/27/25, 9:52 AM